Tag | Content |
---|
EnhancerAtlas ID | HS012-06559 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr11:116795920-116797520 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr11:116796112-116796130 | GGAGTGAAGGAAGGAAGG | + | 7.87 | RARA | MA0729.1 | chr11:116796252-116796270 | GCTTGGACTTCTGACCTC | - | 6.39 |
|
| Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
SE_03999 | chr11:116796374-116798757 | Brain_Anterior_Caudate | SE_10505 | chr11:116794580-116805145 | CD19_Primary | SE_10994 | chr11:116793528-116808338 | CD20 | SE_12256 | chr11:116794956-116797588 | CD3 | SE_16670 | chr11:116794791-116797194 | CD4_Naive_Primary_8pool | SE_20551 | chr11:116795016-116804186 | CD56 | SE_22849 | chr11:116794833-116805633 | CD8_primiary | SE_58687 | chr11:116787398-116806870 | Ly1 | SE_60763 | chr11:116794643-116803965 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I116924 | chr11 | 116795137 | 116804924 |
|
Enhancer Sequence | CGCCACTGCC CTCCTGCCTG GGCAACAGAA TGAGGCCCTG TCTCGAAAAC AAAAACAAAA 60 AAAGGTGGGG GTGGGAGAGA GATGATCCTG GATTATCTGA GACAGCCCAA TGTAATGACA 120 AAGGTCCTTG CAAGAGGGAA GCAGGAGGGT CGGAATTAGG AGTAGGAGAT GTGACAATGG 180 AAGCCACAGG TTGGAGTGAA GGAAGGAAGG GGCTGAGCTA AAGAATGCAG GTGACCTTTA 240 GAAGCTAAAA AAGGCAAGGA CACATTTTTC CTTCAGAGCC TCCAGGAGGA ACAGCCCTTG 300 CTGCTGTTTT AACTTTCACC CTGTGAGACC CAGCTTGGAC TTCTGACCTC CAGAACTACA 360 GGCTAACAAA TCTGTGTTTT TCCAAGTCAT TAAGTTTGTG GTAATTTGTT ATAGTAATAA 420 TAAGACACTA ATCAATCTTT TATTACAGTT TTAAGGGTTG TGAAGTTTAG TAGGTATTAT 480 TAGTATTAAT TTAATTGAAG CTACAACAAA TAATTACAAA AGAAGGTTTG AAATTGCCAG 540 GCTTTTCCAT GCCACACACC TTTGTGGGAA CTACCAGTAT CTATAGAGCT TTGGAGAAAA 600 TAAAACCGAC ATGAGAGCAA AGGAAAAACA TGATTTTATA TAAGATAAAG AAAGCCTTTA 660 ATTCCTGTGT ACTCTGTAAT AAGCTAGTGC AGGAGTGAAA GAACTTATAA ATGATATGAA 720 AGTTCTAAAC AAAAGTGTAG CTGTCAGTTT CAGATATATA AAAAGCTAGG TGATGCTCCA 780 GGATGTAAAA GTGAACAGGC TTATCTACAC AAAAGCAACT CTCAGAAGAA TTGTGACCCT 840 GCAAAGGTAC CCTTAGGTAA CTTTGACCTA TGATAAAAAT CCAAACTCTC AAATCCCACC 900 TCTACTAAGG AAGAAAATCC TTAGAACTGC TTTATACCTT GCCTTTTCTA GACAATTACA 960 TTCTAGCTAT ATTTTAGTTT TCTATATGAG ATGTCCTTCC TTTTATCTGG GAGACCGGGG 1020 ATACACGATG CTATACCGGA AAGTGTCGGC AAACATAAAT GGCTTATTTT CATATTTACA 1080 GTTTCTCTAT AGATTGCAGT CACTTAATTT TATTAGTAAA TGGTGAGTCT GTATTCATTA 1140 GGCAAAATGC TGATAGTTTA CTAAAATTAA GCATGAACAG ATCAAGGCAG TGAAAAGTGC 1200 TCTCAAGGCA CTGTCAGATA AGCAGACTAG TAAAATTTGA GAAGACAAAA AGCTGGACTG 1260 CCTATAAGCC ACTCTAAGAT CTATTTTTCC TAAATTATCA TACAATTACA GCCTTTAGAA 1320 TAAGTATGCT CTGTGTCAGC AGTGACATAA ATCAACCTTC TCAAGTGAAG GTGAGAGGGT 1380 ATACAATTTT AGTAGTTTTC CTTTCCACTT TATTACATAT TTTATTTCTT ATGTAAAAAA 1440 GGACCCGTTA ACCAAAGTAA TAGTATTTTA AATATCACCT TTCCCTTCTT TCTCCCCAGC 1500 CTAGTTCCAG CTGATACTAC ATTAAAAATA AACAGGCCGG GTGTGGTGGC TCACGCCTGT 1560 AATCCCAGCA CTTTGGGAGA CCAAGGCAGG CAGATCACTT 1600
|